3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
20
Precursor Cell Lymphoblastic Leukemia-Lymphoma
15
Burkitt Lymphoma
13
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, Mantle-Cell
3
Leukemia, Biphenotypic, Acute
3
Smoldering Multiple Myeloma
2
Recurrence
2
Plasmacytoma
2
Neoplasms
2
Breast Neoplasms
2
Blast Crisis
2
Waldenstrom Macroglobulinemia
1
Vomiting
1
Squamous Cell Carcinoma of Head and Neck
1
Prostatic Neoplasms
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Pain
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Nausea
1
Myelodysplastic Syndromes
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Plasma Cell
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Interventions
Sorafenib
52
pembrolizumab
26
Nivolumab
20
Bevacizumab
19
Radiosurgery
17
Doxorubicin
12
atezolizumab
9
Erlotinib Hydrochloride
9
lenvatinib
8
cabozantinib
7
Magnetic Resonance Spectroscopy
7
tremelimumab
6
durvalumab
6
Ramucirumab
6
Radiofrequency Ablation
6
Cisplatin
6
Sunitinib
5
tislelizumab
4
regorafenib
4
Oxaliplatin
4
Leucovorin
4
Ipilimumab
4
Fluorouracil
4
Everolimus
4
Capecitabine
4
nintedanib
3
fluoromisonidazole
3
carotuximab
3
bavituximab
3
Tomography, X-Ray Computed
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Hepatocellular
×
auricularum
×
Clear all
No trials found.